The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Interim results of a multicenter phase II trial of nab-paclitaxel (nab-P) plus gemcitabine (G) for patients (Pts) with locally advanced pancreatic cancer (LAPC).
 
Jill Lacy
Consulting or Advisory Role - Sirtex Medical
 
Fabienne Portales
Honoraria - Sanofi
Travel, Accommodations, Expenses - Roche
 
Pascal Hammel
Honoraria - Celgene
Consulting or Advisory Role - Celgene
Travel, Accommodations, Expenses - Celgene
 
Roberto A. Pazo Cid
No Relationships to Disclose
 
Jose Luis Manzano Mozo
No Relationships to Disclose
 
Edward Jae-hoon Kim
Honoraria - Guardant Health
Consulting or Advisory Role - Bayer; Guardant Health; Medallion; Momenta Pharmaceuticals; Pharmacyclics
Speakers' Bureau - Guardant Health
 
Scot D. Dowden
Honoraria - Celgene; Lilly; Roche Canada; Sanofi
Consulting or Advisory Role - Celgene; Lilly; Roche Canada; Sanofi
Speakers' Bureau - Amgen; Celgene; Roche Canada
 
Christophe Borg
Consulting or Advisory Role - Celgene; Lilly; Roche
Research Funding - Roche
 
Javier Sastre
No Relationships to Disclose
 
Venu Gopal Bathini
Research Funding - Celgene
 
Eric Terrebonne
No Relationships to Disclose
 
Daniel Lopez-Trabada
No Relationships to Disclose
 
Fernando Rivera
Consulting or Advisory Role - Amgen; Bayer; Celgene; Lilly; Merck Serono; MSD; Roche; Sanofi
Speakers' Bureau - Amgen; Bayer; Celgene; Lilly; Roche; Sanofi
Research Funding - Bayer; Celgene; Lilly; Merck Serono; MSD; Roche; Sanofi
 
Jamil Asselah
No Relationships to Disclose
 
Azzurra Damiani
No Relationships to Disclose
 
Jimmy J. Hwang
Consulting or Advisory Role - Amgen; Bayer; Genentech/Roche; Merrimack; Sanofi; Taiho Pharmaceutical
Speakers' Bureau - Amgen; Bayer/Onyx; Celgene; Genentech/Roche
Expert Testimony - Roche
 
Teng Jin Ong
Employment - Celgene
Leadership - Celgene
Stock and Other Ownership Interests - Celgene
 
Thom Nydam
Employment - Celgene
Leadership - Celgene
Stock and Other Ownership Interests - Celgene
 
Jack Shiansong Li
Employment - Celgene
Leadership - Celgene
Stock and Other Ownership Interests - Celgene
 
Philip Agop Philip
Honoraria - Amgen; Bayer; Bristol-Myers Squibb; Celgene; Halozyme; Ipsen; Merrimack; Novartis; Roche; Sanofi
Consulting or Advisory Role - Celgene; Gilead Sciences; Halozyme; Ipsen; Merrimack; novartis
Speakers' Bureau - amgen; Bayer; Celgene; roche; sanofi
Research Funding - Bayer (Inst); Genentech (Inst); Immunomedics (Inst); incyte (Inst); Karyopharm Therapeutics (Inst); Merck (Inst); Momenta Pharmaceuticals (Inst); novartis (Inst); Plexxikon (Inst); Regeneron (Inst); Taiho Pharmaceutical (Inst)
Other Relationship - Celgene; emd serono; Halozyme; Roche; sanofi